Other OTC - Delayed Quote • USD
IDenta Corp. (IDTA)
At close: April 4 at 10:21 AM EDT
Key Executives
Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Mr. Amichai Glattstein | CEO & Director | -- | -- | -- |
Mr. Baruch Glattstein | Co-Founder & CTO | -- | -- | -- |
Mr. Mishael Spitzer | Chief Operating Officer | -- | -- | -- |
IDenta Corp.
- Sector:
- Healthcare
- Industry: Diagnostics & Research
Description
IDenta Corp. operates as a detection and forensic science company. The company offers drug, explosives, bullet-hole testing, and phenolphthalein blood detection kits; aero chamber sniffer; and FerroPrint testing products. It provides its solutions to law enforcement, military, and government agencies, as well as other organizations that deal in fighting illicit drugs and terrorist threats. The company has operations in the Israel, United States, the United Nations, DEA, Germany, France, Italy, Spain, Indonesia, Brazil, Mexico, South Africa, Nigeria, Canada, and internationally. IDenta Corp. was founded in 2002 and is headquartered in Jerusalem, Israel.
Corporate Governance
IDenta Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Recent Events
- Jun 20, 2017Dividend Date
Upcoming Events
Upcoming Events Information Not Available